A Doctor’s Truth About Weight Loss:
Why Most Diets Fail—And What Actually Works

AS SEEN IN:

Scientific References:

Wilding, J.P.H., et al. (2021)
Once‑Weekly Semaglutide in Adults with Overweight or Obesity
Journal: New England Journal of Medicine, 384(11):989‑1002
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

Jastreboff, A.M., et al. (2022)
Tirzepatide Once Weekly for the Treatment of Obesity
Journal: New England Journal of Medicine, 387(3):205‑216
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

Garvey, W.T., et al. (2022)
Two‑Year Effects of Semaglutide in Adults with Overweight or Obesity: The STEP 5 Trial
Journal: Nature Medicine, 28(10):2083‑2091
Link: https://www.nature.com/articles/s41591-022-02026-4

Wadden, T.A., et al. (2021)
Effect of Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT‑4 Randomized Clinical Trial
Journal: JAMA, 325(14):1403‑1413
Link: https://jamanetwork.com/journals/jama/fullarticle/2812936

Harvard Health Publishing. (2023)
Semaglutide for Weight Loss: What You Need to Know
Source: Harvard Health Blog
Link: https://www.health.harvard.edu/staying-healthy/semaglutide-for-weight-loss-what-you-need-to-know

Apovian, C.M., et al. (2015).
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Journal: Journal of Clinical Endocrinology & Metabolism, 100(2):342‑362
Link: https://academic.oup.com/jcem/article/100/2/342/2833058

Rubino, D., et al. (2021).
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
Journal: JAMA, 325(14):1414‑1425
Link: https://jamanetwork.com/journals/jama/fullarticle/2783729

Ahrén, B., et al. (2017).
Efficacy and Safety of Once‑Weekly Semaglutide vs Once‑Daily Sitagliptin as an Add‑On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 2)
Journal: Lancet Diabetes & Endocrinology, 5(5):341‑354
Link: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(17)30092-X/fulltext

Lee, J.H., et al. (2020).
Impact of GLP‑1 Receptor Agonists on Weight Loss and Cardiometabolic Outcomes: A Systematic Review and Meta‑Analysis
Journal: Obesity Reviews
Link: https://onlinelibrary.wiley.com/doi/full/10.1111/obr.13031

Neoh, S.L., et al. (2014).
Combination Phentermine and Topiramate for Weight Maintenance: The First Australian Experience
Journal: Medical Journal of Australia, 201(4):224‑226
Link: https://www.mja.com.au/journal/2014/201/4/combination-phentermine-and-topiramate-weight-maintenance-first-australian-experience

Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The content provided is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting any weight loss, exercise, or medication regimen.